ArticleViruses2021
Clusters of SARS-CoV-2 Lineage B.1.1.7 Infection after Vaccination with Adenovirus-Vectored and Inactivated Vaccines.
Open access · goldAbstract read
In one paragraph
Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 31% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.
- SARS-CoV-2 Genomic Surveillance in Brazil: A Systematic Review with Scientometric Analysis.Viruses · 2022Pooled it
- Replication differences of SARS-CoV-2 lineages may arise from unique RNA replication characteristics and nucleocapsid protein expression.Frontiers in cellular and infection microbiology · 2025Article
- A global epidemiological analysis of COVID-19 vaccine types and clinical outcomes.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022Article
- Characteristics of COVID-19 Breakthrough Infections among Vaccinated Individuals and Associated Risk Factors: A Systematic Review.Tropical medicine and infectious disease · 2022Review
- CoronaVac and ChAdOx1 Vaccination and Gamma Infection Elicited Neutralizing Antibodies against the SARS-CoV-2 Delta Variant.Viruses · 2022Article
- SARS-CoV-2's Variants of Concern: A Brief Characterization.Frontiers in immunology · 2022Review
- Protective Immunity against Gamma and Zeta Variants after Inactivated SARS-CoV-2 Virus Immunization.Viruses · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
34 authors at 5 institutions in 3 countries.
William M de SouzaVirology Research Centre, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Stéfanie P MuraroLaboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas 13083-862, Brazil.ORCID 0000-0002-5105-6659
Gabriela F SouzaLaboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas 13083-862, Brazil.
Mariene R AmorimLaboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas 13083-862, Brazil.ORCID 0000-0002-8516-0155
Renata Sesti-CostaBrazilian Biosciences National Laboratory, Brazilian Centre for Research in Energy and Materials, Campinas 13083-100, Brazil.ORCID 0000-0002-7098-2850
Luciana S MofattoLaboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas 13083-862, Brazil.
Julia ForatoLaboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas 13083-862, Brazil.
Priscilla P BarbosaLaboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas 13083-862, Brazil.
Daniel A Toledo-TeixeiraLaboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas 13083-862, Brazil.ORCID 0000-0002-4055-058X
Karina Bispo-Dos-SantosLaboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas 13083-862, Brazil.
Pierina L PariseLaboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas 13083-862, Brazil.ORCID 0000-0003-2818-1301
Natalia S BrunettiAutoimmune Research Laboratory, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas 13083-862, Brazil.ORCID 0000-0003-2803-3763
Joselia C O MoreiraDepartment of Structural and Functional Biology, Institute of Biology, University of Campinas, Campinas 13083-862, Brazil.
Vitor A CostaHematology and Hemotherapy Center, University of Campinas, Campinas 13083-862, Brazil.
Daniela M CardozoDepartment of Clinical Pathology, School of Medical Sciences, University of Campinas, Campinas 13083-862, Brazil.
Maria L MorettiDepartment of Internal Medicine, School of Medical Sciences, University of Campinas, Campinas 13083-862, Brazil.
Silvia Barros-MazonDepartment of Clinical Pathology, School of Medical Sciences, University of Campinas, Campinas 13083-862, Brazil.
Gabriela F MarchesiCampinas Department of Public Health Surveillance, Campinas 13015-904, Brazil.
Christiane AmbrosioCampinas Department of Public Health Surveillance, Campinas 13015-904, Brazil.
Fernando R SpilkiOne Health Laboratory, Feevale University, Novo Hamburgo 93510-235, Brazil.ORCID 0000-0001-5804-7045
Valeria C AlmeidaCampinas Department of Public Health Surveillance, Campinas 13015-904, Brazil.ORCID 0000-0002-4027-7835
Andre S VieiraDepartment of Structural and Functional Biology, Institute of Biology, University of Campinas, Campinas 13083-862, Brazil.
Lair ZambonDepartment of Internal Medicine, School of Medical Sciences, University of Campinas, Campinas 13083-862, Brazil.
Alessandro S FariasAutoimmune Research Laboratory, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas 13083-862, Brazil.
Marcelo Addas-CarvalhoHematology and Hemotherapy Center, University of Campinas, Campinas 13083-862, Brazil.ORCID 0000-0003-0178-6191
Bruno D BenitesHematology and Hemotherapy Center, University of Campinas, Campinas 13083-862, Brazil.ORCID 0000-0003-3985-5690
Rafael E MarquesBrazilian Biosciences National Laboratory, Brazilian Centre for Research in Energy and Materials, Campinas 13083-100, Brazil.ORCID 0000-0002-6949-0947
Ester C SabinoTropical Medicine Institute, Medical School, University of São Paulo, São Paulo 05403-907, Brazil.
Andrea B Von ZubenCampinas Department of Public Health Surveillance, Campinas 13015-904, Brazil.
Scott C WeaverDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.ORCID 0000-0001-8016-8556
Nuno R FariaDepartment of Infectious and Parasitic Disease, Medical School, University of São Paulo, São Paulo 05403-000, Brazil.
Fabiana GranjaLaboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas 13083-862, Brazil.ORCID 0000-0003-3602-8550
Rodrigo N AngeramiDepartment of Internal Medicine, School of Medical Sciences, University of Campinas, Campinas 13083-862, Brazil.ORCID 0000-0002-4976-9238
José Luiz Proença-MódenaLaboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas 13083-862, Brazil.ORCID 0000-0002-4996-3153
Universidade Estadual de Campinas (UNICAMP) · BRUniversidade de São Paulo · BRBrazilian Biosciences National Laboratory · BRThe University of Texas Medical Branch at Galveston · USUniversidade Feevale · BR
Funding
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)R24AI120942 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI WEAVER, SCOTT C · 2016 to 2024
$8.5MMedical Research Council MC_PC_19012Medical Research Council MR/R015600/1Medical Research Council MR/S019510/1National Council for Scientific and Technological Development 305628/2020-8; 408338/2018-0NIAID NIH HHS R24 AI120942NIH HHS AI120942São Paulo Research Foundation 2016/00194-8; 2020/04558-0;2017/13981-0; 2019/24251-9;2018/13645-3, 2018/10224-7, 2020/02159-0, 2017/26908-0; 2018/14389-0Wellcome Trust 204311/Z/16/Z
Abstract
A SARS-CoV-2 B.1.1.7 variant of concern (VOC) has been associated with increased transmissibility, hospitalization, and mortality. This study aimed to explore the factors associated with B.1.1.7 VOC infection in the context of vaccination. On March 2021, we detected SARS-CoV-2 RNA in nasopharyngeal samples from 14 of 22 individuals vaccinated with a single-dose of ChAdOx1 (outbreak A,
Indexed as
COVID-19 VaccinesVaccinationAdenoviridaeAdultAgedAged, 80 and overAntibodies, NeutralizingBrazilBreakthrough InfectionsCohort StudiesCOVID-19COVID-19 Serological TestingDisease OutbreaksFemaleGenetic VectorsHumansAntibodies, NeutralizingCOVID-19 VaccinesImmunoglobulin GRNA, ViralVaccines, InactivatedB.1.1.7COVID-19outbreakSARS-CoV-2vaccinevariant of concern
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.